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Abstract: BACKGROUND: Initiation, amplitude, duration and termination of transforming growth fac-
tor ￿ (TGF￿) signaling via Smad proteins is regulated by post-translational modifications, including phos-
phorylation, ubiquitination and acetylation. We previously reported that ADP-ribosylation of Smads by
poly(ADP-ribose) polymerase 1 (PARP-1) negatively influences Smad-mediated transcription. PARP-1
is known to functionally interact with PARP-2 in the nucleus and the enzyme poly(ADP-ribose) glycohy-
drolase (PARG) can remove poly(ADP-ribose) chains from target proteins. Here we aimed at analyzing
possible cooperation between PARP-1, PARP-2 and PARG in regulation of TGF￿ signaling. METHODS:
A robust cell model of TGF￿ signaling, i.e. human HaCaT keratinocytes, was used. Endogenous Smad3
ADP-ribosylation and protein complexes between Smads and PARPs were studied using proximity liga-
tion assays and co-immunoprecipitation assays, which were complemented by in vitro ADP-ribosylation
assays using recombinant proteins. Real-time RT-PCR analysis of mRNA levels and promoter-reporter
assays provided quantitative analysis of gene expression in response to TGF￿ stimulation and after ge-
netic perturbations of PARP-1/-2 and PARG based on RNA interference. RESULTS: TGF￿ signaling
rapidly induces nuclear ADP-ribosylation of Smad3 that coincides with a relative enhancement of nu-
clear complexes of Smads with PARP-1 and PARP-2. Inversely, PARG interacts with Smads and can
de-ADP-ribosylate Smad3 in vitro. PARP-1 and PARP-2 also form complexes with each other, and
Smads interact and activate auto-ADP-ribosylation of both PARP-1 and PARP-2. PARP-2, similar to
PARP-1, negatively regulates specific TGF￿ target genes (fibronectin, Smad7) and Smad transcriptional
responses, and PARG positively regulates these genes. Accordingly, inhibition of TGF￿-mediated tran-
scription caused by silencing endogenous PARG expression could be relieved after simultaneous depletion
of PARP-1. CONCLUSION: Nuclear Smad function is negatively regulated by PARP-1 that is assisted
by PARP-2 and positively regulated by PARG during the course of TGF￿ signaling.
DOI: 10.1371/journal.pone.0103651
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Abstract
Background: Initiation, amplitude, duration and termination of transforming growth factor b (TGFb) signaling via Smad
proteins is regulated by post-translational modifications, including phosphorylation, ubiquitination and acetylation. We
previously reported that ADP-ribosylation of Smads by poly(ADP-ribose) polymerase 1 (PARP-1) negatively influences Smad-
mediated transcription. PARP-1 is known to functionally interact with PARP-2 in the nucleus and the enzyme poly(ADP-
ribose) glycohydrolase (PARG) can remove poly(ADP-ribose) chains from target proteins. Here we aimed at analyzing
possible cooperation between PARP-1, PARP-2 and PARG in regulation of TGFb signaling.
Methods: A robust cell model of TGFb signaling, i.e. human HaCaT keratinocytes, was used. Endogenous Smad3 ADP-
ribosylation and protein complexes between Smads and PARPs were studied using proximity ligation assays and co-
immunoprecipitation assays, which were complemented by in vitro ADP-ribosylation assays using recombinant proteins.
Real-time RT-PCR analysis of mRNA levels and promoter-reporter assays provided quantitative analysis of gene expression in
response to TGFb stimulation and after genetic perturbations of PARP-1/-2 and PARG based on RNA interference.
Results: TGFb signaling rapidly induces nuclear ADP-ribosylation of Smad3 that coincides with a relative enhancement of
nuclear complexes of Smads with PARP-1 and PARP-2. Inversely, PARG interacts with Smads and can de-ADP-ribosylate
Smad3 in vitro. PARP-1 and PARP-2 also form complexes with each other, and Smads interact and activate auto-ADP-
ribosylation of both PARP-1 and PARP-2. PARP-2, similar to PARP-1, negatively regulates specific TGFb target genes
(fibronectin, Smad7) and Smad transcriptional responses, and PARG positively regulates these genes. Accordingly, inhibition
of TGFb-mediated transcription caused by silencing endogenous PARG expression could be relieved after simultaneous
depletion of PARP-1.
Conclusion: Nuclear Smad function is negatively regulated by PARP-1 that is assisted by PARP-2 and positively regulated by
PARG during the course of TGFb signaling.
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Introduction
Signal transduction pathways, including transforming growth
factor b (TGFb), are controlled by negative regulatory mecha-
nisms [1,2,3]. The TGFb pathway is extensively studied due to its
implication in early embryonic development, in specification of
different organs, in homeostatic regulation of adult tissue integrity
and due to its role in the development and progression of many
diseases, including cardiovascular, fibrotic and malignant diseases
[4,5]. In the TGFb pathway, negative regulation is exerted at
multiple levels: at the level of the extracellular ligand and its access
to the signaling receptors [6]; at the level of the type I and type II
receptors that have serine/threonine kinase activity and phos-
phorylate intracellular Smad proteins or other signaling proteins
[7]; at the level of the Smad proteins that form complexes with
each other, e.g. the receptor-phosphorylated Smad2 and Smad3
(R-Smads) associate with Smad4 and together accumulate in the
nucleus to regulate transcription [2]; and finally, at the level of
many of the cytoplasmic and nuclear cofactors of the receptors and
Smads, which are themselves regulated based on crosstalk with
many other signaling pathways, and which provide the ‘‘context-
dependent’’ function of the pathway [3,8].
We recently established a mechanism of negative regulation of
Smad activity taking place in the nucleus, based on the finding that
Smad3 and Smad4 can associate with the nuclear ADP-ribosyl-
transferase (ADP-ribosyltransferase diphtheria toxin-like 1,
ARTD1), also known as poly(ADP-ribose) polymerase-1 (PARP-
1) [9]. PARP-1 binds to Smad proteins and ADP-ribosylates them
proximal to their DNA-binding domain, thus reducing their
affinity to DNA and negatively regulating their transcriptional
activity. A straightforward consequence of this biochemical
modification is that PARP-1 negatively regulates gene responses
to TGFb signaling [9]. In a similar manner, PARP-1 suppresses
the expression of TGFb receptors in CD4-positive T cells and for
this reason PARP-1 inhibitors enhance signaling by TGFb [10]. In
addition, PARP-1 can mediate positive gene responses to TGFb as
reported in studies of vascular smooth muscle cells [11]. A
potential dual role of PARP-1 in mediating transcriptional
responses is compatible with the current understanding of
PARP-1 as a positive or negative regulator of transcription [12].
PARP-1 is the prototype of a large family of ADP-ribosyl-
transferases (ARTDs) that enlists eighteen members acting towards
diverse substrates in the nucleus, cytoplasm or mitochondria
[12,13,14]. PARP-1 is best understood for its role in the DNA
damage and repair response and the surveillance mechanisms that
guarantee genomic integrity. Equally well established is the role of
PARP-1 as a regulator of physiological transcription during
embryonic development and adult tissue homeostasis [12,13].
During transcription, PARP-1 builds poly(ADP)-ribose (PAR)
chains on histones inside nucleosomes, affects the binding of
histone H1 to nucleosomes, regulates DNA methylation, ADP-
ribosylates the chromatin insulator protein CTCF and many
DNA-binding transcription factors by modulating (usually nega-
tively) their binding to DNA [12,13]. In addition, PARP-1 and
other PARP family members are known to auto-ADP-ribosylate as
a mechanism that regulates their activity and residence to
chromatin [15].
PARP-2 (ARTD2) is the second member of the family, it also
localizes in the nucleus and shares a highly conserved catalytic
domain with PARP-1 [14], however, it is a smaller protein, lacking
many of the protein-protein interaction domains of PARP-1 and
having a short N-terminal nuclear localization domain [16].
PARP-2 functions in a relatively similar manner with PARP-1 as
both enzymes are intimately involved in the DNA-damage and
repair response, chromatin remodeling and transcription and in
the development of cancer [17]. During the DNA damage and
nucleotide base excision-repair mechanisms PARP-2 functionally
cooperates with PARP-1 by forming physical complexes with each
other and affecting each other’s catalytic activity [18]. In addition,
PARP-2 can associate with the regulatory sequences of genes, such
as SIRT1, an NAD-dependent deacetylase, repressing its expres-
sion and providing a mechanism that limits energy expenditure
and mitochondrial function [19]. Interestingly, such transcription-
al function of PARP-2 can be directly regulated by the histone
acetyl-transferase P/CAF, which acetylates the N-terminal domain
of PARP-2 and reduces the DNA-binding and auto-ADP-
ribosylation activity of PARP-2 [20].
Protein ADP-ribosylation mediated by PARP-1 is dynamic and
its turnover is controlled in part by the action of the enzyme
poly(ADP-ribose) glycohydrolase (PARG) [21]. PARG can hydro-
lyze PAR chains, whereas mono(ADP-ribosyl) units are removed
from target proteins by the action of the ADP-ribosyl hydrolase 3
(ARH3) and macrodomain-containing proteins such as MacroD1
[22]. A clear function of PARG is the regulation of chromatin
remodeling during transcription as it antagonizes the functional
effects of PARP-1 [23]. Genome-wide location analysis has
demonstrated that both PARP-1 and PARG localize in distinct
sets of gene regulatory sequences [24,25]. Evidence based on
comparative RNAi of PARP-1 versus PARG in breast cancer cells
proposed that the two enzymes regulate gene expression in a
coordinate and non-antagonistic manner, an intriguing finding
that requires future mechanistic explanation [24].
In this investigation we analyzed the role of PARP-2 and PARG
in association to PARP-1 during TGFb signaling. Using proximity
ligation assays (PLA) and immunoprecipitations, we demonstrate
that TGFb induces endogenous PARP-1/Smad3 and PARP-2/
Smad2/3 complexes, while only having small effects on the
PARP1/PARP-2 interaction. TGFb also promotes endogenous
Smad3 oligo(ADP-ribosyl)ation, while in vitro ADP-ribosylation
experiments demonstrated that recombinant Smad3 or Smad4
could co-precipitate activated poly(ADP-ribosyl)ated PARP-1 and
PARP-2. During TGFb-regulated transcription, PARP-2 may act
functionally in a similar manner as PARP-1, since PARP-2
suppressed TGFb/Smad-dependent transcriptional responses.
Finally, after demonstrating that PARG is capable of interacting
with Smad proteins and de-ADP-ribosylating Smad3, we found
that PARG is required for optimal transcriptional responses to
TGFb. Thus, in the case of TGFb-mediated transcriptional
regulation, PARP-2 complements PARP-1’s negative regulation of
nuclear Smad function, while PARG seems to antagonize PARP-
1/2 and provide a balancing mechanism for the optimal control of
signal-regulated transcription.
Results
Induction of ADP-ribosylation by TGFb
We have previously provided evidence for the biochemical
association of PARP-1 with Smad3 and Smad4, and for in vitro
ADP-ribosylation of Smad3 and Smad4 [9]. In the present work
we explored alternative techniques in order to demonstrate and
quantify the extent of Smad protein ADP-ribosylation in living
cells responding to TGFb stimulation. We obtained reliable results
when we applied in situ PLA [26], which provides a sensitive and
quantitative method for detecting protein complexes or post-
translational modifications of proteins. We focused mainly on
Smad3, as this Smad associates stronger with PARP-1 and
becomes ADP-ribosylated [9]. Using human immortalized kera-
tinocytes (HaCaT) that are responsive to TGFb signaling, we
PARP-1, PARP-2 and PARG Regulate Smad Function
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could observe rolling circle amplification (RCA) signals after
applying antibodies against Smad3 and against PAR chains
(Fig. 1). In the absence of TGFb stimulation, very weak Smad3
ADP-ribosylation was detected that was indistinguishable from the
negative controls of Smad3 or PAR antibody alone (Fig. 1). In
contrast, TGFb rapidly induced nuclear RCA signals that
presumably represent ADP-ribosylation of Smad3 (Fig. 1). After
quantification of the nuclear RCA signals using the DuolinkIma-
geTool software, we could verify that nuclear ADP-ribosylation
was induced at 5 min, was further enhanced at 10 min, already
declined significantly at 20 min, and returned to steady but low
levels up to 90 min after TGFb stimulation (Fig. 1b), and the same
low level persisted even up to 6 h after TGFb stimulation (data not
shown). Attempts to link the nuclear signals of Smad3-PAR to the
activity of PARP-1 or PARP-2 using siRNA-mediated silencing of
each protein failed for technical reasons, as PLA with the PAR
antibody repeatedly failed when the cells were transfected (data
not shown). As a positive control, we measured the endogenous
Smad3 ADP-ribosylation after cell exposure to a rapid and acute
dose of hydrogen peroxide (Fig. 1), which is known to induce
strong PARP activity in the nucleus and can also induce stable
Smad3-PARP-1 complexes [9]. Peroxide treatment in the absence
of TGFb stimulation caused dramatically higher levels of Smad3-
PAR in the nuclei of HaCaT cells (Fig. 1). We conclude that PLA
can reliably monitor endogenous Smad3 ADP-ribosylation in
human cells in culture. This method allowed us for the first time to
observe the rapid and relatively transient time course of Smad3
ADP-ribosylation in response to TGFb signaling.
TGFb promotes protein complexes between Smads,
PARP-1 and PARP-2
We then analyzed endogenous complexes between Smad3 and
PARP-1 using PLA, which also allowed us to simultaneously
monitor the subcellular distribution of the complexes. We
observed RCA signals derived from Smad3/PARP-1 protein
complexes, exclusively in the nucleus (Fig. 2). After quantitation of
the nuclear RCA signals we could verify that more than 95% of
the cells in the epithelial monolayer exhibited detectable Smad3/
PARP-1 complexes (Fig. 2b).
Smad3/PARP-1 complexes occurred even in the absence of
TGFb stimulation, but the incidence of complexes was higher after
TGFb stimulation for 0.5 h and lower after 1.5 h stimulation
(Fig. 2b), which persisted even up to 6 h after TGFb stimulation
(data not shown). As a positive control, we measured the
endogenous Smad3/PARP-1 complexes after exposure of cells to
a rapid and acute dose of hydrogen peroxide, which led to a very
dramatic accumulation of the nuclear RCA signals that was much
stronger than the accumulation achieved by TGFb (Fig. 2a).
Multiple negative controls ascertained the specificity of detection
of the endogenous Smad3/PARP-1 complexes: a) silencing of
PARP-1 using siRNA reduced the nuclear RCA signals to almost
background levels (Fig. 2). Similarly, silencing of PARP-1 signif-
icantly reduced the Smad3/PARP-1 complexes after cell treat-
ment with peroxide (Fig. 2a). b) Silencing PARP-2 using siRNA
only weakly reduced the observed Smad3/PARP-1 complexes,
suggesting that PARP-2 is not essential for the formation of
complexes between R-Smad and PARP-1 but contributes partially
to the formation of the complexes (Fig. 2). c) Controls with single
PARP-1 or Smad3 antibody gave the absolute background signal
of this assay (Fig. 2a).
Formation of endogenous complexes between PARP-2 and R-
Smads using the PLA approach in HaCaT cells after TGFb or
peroxide treatment was also studied (Fig. 3). Once more, PLA-
positive RCA products were detected in the nucleus. The
incidence of R-Smad/PARP-2 complexes was higher after TGFb
stimulation especially at 0.5 h and lower after 1.5 h (Fig. 3), and
persisted even up to 6 h after TGFb stimulation (data not shown),
while they were also increased by peroxide treatment (Fig. 3a).
The negative controls of PLA with single antibodies and silencing
of PARP-2 with the siRNA showed high degree of specificity in the
analysis (Fig. 3). Interestingly, when the endogenous PARP-1 was
silenced the R-Smad/PARP-2 complexes were significantly but
not dramatically decreased (Fig. 3b), suggesting that PARP-1 only
partly contributes to the formation of the complex between PARP-
2 and R-Smad.
Subsequently, we studied protein interactions by performing
immunoprecipitation assays in embryonic kidney cells under
conditions where all three Smad proteins (Smad2, Smad3 and
Smad4) were overexpressed at stoichiometric levels to simulate
endogenous Smad signaling (Fig. 4a). We have found that
expression of all three Smads leads to the formation of robust
levels of Smad complexes and probing the cells with antibodies
against the phosphorylated C-terminal of Smad2 or Smad3
indicated strong activation of these Smads, as if the cells produced
autocrine TGFb (data not shown). Both endogenous PARP-1 and
PARP-2 were co-precipitated with the three Smads. The PARP-2
antibody used recognized two near migrating protein bands
(Fig. 4a) that both represent PARP-2 protein as both are lost after
PARP-2-specific silencing (Fig. 4c). Interestingly only the slower
migrating PARP-2 species co-precipitated with the Smads, while
the faster migrating PARP-2 protein species showed weak
association with the Smads (Fig. 4a). We currently do not
understand the reason behind this observation.
We also detected endogenous complexes between R-Smad
(Smad2/3) and PARP-1 and PARP-2 in HaCaT cells that were
used for the PLA analysis (Fig. 4b). In this endogenous co-
precipitation, PARP-1 formed complexes with R-Smads only after
0.5 h stimulation with TGFb (Fig. 4b). PARP-2 associated with R-
Smads even without TGFb stimulation, but its association was
enhanced after stimulation (Fig. 4b). Immunoblotting with a
Smad4 antibody revealed the TGFb-dependent association of
endogenous Smad4 with Smad2/3, serving as positive control of
functional TGFb signaling (Fig. 4b). Use of an isotype-matched
control immunoglobulin (IgG) for the immunoprecipitation
demonstrated very low level of co-precipitating non-specific
proteins binding to the Smads (Fig. 4b). By performing the
siRNA-mediated knockdowns of each PARP protein, as done in
the PLA assay (Fig. 2, 3), we confirmed that TGFb signaling
promotes distinct complexes of R-Smads with PARP-1 and with
PARP-2, as well as with Smad4, the positive control for signaling
(Fig. 4c). Thus, silencing 80–90% of PARP-1 caused loss of R-
Smad/PARP-1 complexes, but did not affect the R-Smad/PARP-
2 complexes. Similarly, loss of 90% of PARP-2 did not affect the
R-Smad/PARP-1 complexes (Fig. 4c). It is worth noting that by
comparing PLA (Fig. 2, 3) with co-immunoprecipitation assays
(Fig. 4b, c), it appears as TGFb is strongly required for formation
of endogenous R-Smad/PARP complexes as judged by co-
precipitation assay (Fig. 4b, c), while such complexes occur also
in the absence of TGFb stimulation as judged by PLA (Fig. 2, 3).
This may reflect the fact that PLA measures proximity between
proteins but not necessarily formation of stable complexes,
whereas the co-precipitation assay, especially after stringent
washes with salt, measures the formation of more stable protein
complexes. Furthermore, this difference could also indicate that
the phosphorylation of Smads leads to a stronger and more stable
interaction with PARP1 and PARP2 that better endures the
immunoprecipitation protocol. We conclude that TGFb signaling
PARP-1, PARP-2 and PARG Regulate Smad Function
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rapidly promotes R-Smad/PARP1 and R-Smad/PARP-2 com-
plexes that reside in the nucleus.
Induction of ADP-ribosylation by Smad proteins
The in vivo ADP-ribosylation of endogenous Smad3 (Fig. 1)
and the endogenous complexes between R-Smad and PARP-1/2
Figure 1. PLA of endogenous Smad3 ADP-ribosylation after TGFb stimulation in HaCaT cells. (a) HaCaT cells were analyzed with PLA
using antibodies against Smad3 and PAR chains after stimulation with vehicle (0 min) or with 2 ng/ml TGFb1 for the indicated time periods. Specific
RCA signals were detected in the nuclei. Cells stimulated with 10 mM hydrogen peroxide for 10 min served as positive control. PLA with single
antibodies against Smad3 or PAR are shown as controls. PLA signals are shown in red, blue is DAPI staining for DNA and green is phalloidin staining
for the actin cytoskeleton as a measure of overall cell architecture. (b) Quantification of the experiment shown in panel (a) using the
DuolinkImageTool, with data plotted as a histogram divided in three classes according to the percent of cells that exhibit specific RCA signals: very
low, 0–2 signals per cell [green]; low, 3–10 signals per cell [grey]; and high, .11 signals per cell [red]. The figure shows a representative experiment
from three or more repeats.
doi:10.1371/journal.pone.0103651.g001
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(Fig. 2–4) prompted further in vitro experiments. We previously
reported that Smad3 and Smad4 are ADP-ribosylated by PARP-1
and also enhance auto-ADP-ribosylation of PARP-1 in vitro [9].
We now tested the capacity of purified Smad proteins to associate
with PARP-1 and PARP-2 and become poly(ADP-ribosyl)ated,
using in vitro ADP-ribosylation assays (Fig. 4d). Recombinant
GST-Smads isolated from E. coli (Fig. S1) and insect cell-derived
PARP-1 and PARP-2 purified after baculovirus infection were
added in reactions together with radioactive b-NAD, which served
as the tracer that can reveal ADP-ribosylation on any of the
proteins included in the reaction after separation on SDS-PAGE
(Fig. 4d). In addition, since the Smad proteins used were tagged
with GST, we could perform glutathione-based pull down assays
followed by SDS-PAGE, which allowed us to monitor ADP-
ribosylated proteins simultaneously with their ability to form
complexes and co-precipitate together (Fig. 4d). In these experi-
ments we tested three specific Smad variants, full length Smad3 N-
terminally fused to GST, GST-Smad3 lacking its C-terminal Mad
homology 2 (MH2) domain (GST-Smad3 DMH2) and full length
GST-Smad4. The proteins were mixed in the same reaction vessel,
incubated with radioactive b-NAD for 30 min and then proteins
were precipitated; after washing, the samples were resolved by
SDS-PAGE followed by autoradiography.
Using PARP-1 and PARP-2 together with GST as control, we
observed only weak poly(ADP-ribosyl)ation of PARP-1, and very
low levels of PARP-2 poly(ADP-ribosyl)ation (Fig. 4d, lanes 1, 12;
stars indicate PARP-2 migration). Co-incubation of PARP-1 with
GST-Smad3 led to a robust ADP-ribosylation of Smad3 (Fig. 4d,
lane 3) as previously established [9], and reproduced the enhanced
complex formation and activation of PARP-1 poly(ADP-ribosyl)a-
tion (Fig. 4d, compare the PARP-1 band in lanes 1 and 3).
Addition of PARP-2 in the reaction together with PARP-1 and
GST-Smad3 did not enhance Smad3 ADP-ribosylation but led to
weak but detectable and reproducible poly(ADP-ribosyl)ation of
PARP-2 (Fig. 4d, lane 5). Similar results were obtained with GST-
Smad3 DMH2 (Fig. 4d, lanes 8–10), however, PARP-2 migrated
exactly at the same position as GST-Smad3 DMH2 prohibiting us
from observing effects on PARP-2 ADP-ribosylation; moreover,
this deletion mutant led to detection of a more robust poly(ADP-
ribosyl)ation of PARP-1 and itself, as previously described [9], due
to the tighter association of the N-terminal Smad3 domain (MH1)
with PARP-1. Interestingly, when GST-Smad4 was incubated
with PARPs, we observed ADP-ribosylation of Smad4, but less
efficient than the ADP-ribosylation of Smad3 as previously
explained [9]. However, Smad4 led to more efficient detection
of auto-poly(ADP-ribosyl)ation of PARP-1 than Smad3 (see thick
smear migrating upwards in Fig. 4d, lanes 14, 16) and the
poly(ADP-ribosyl)ation of PARP-2 was correspondingly enhanced
(see long exposure in Fig. 4d). PARP-2 alone did not ADP-
ribosylate Smads (Fig. 4d, lanes 4, 9, 15). As a control, excess
amount of GST protein did not co-precipitate ADP-ribosylated
proteins, neither did GST become ADP-ribosylated (Fig. 4d, lanes
1, 12).
The above experiments reconfirmed our previous results that
Smad3 and Smad4 can be directly ADP-ribosylated by PARP-1,
and of the ability of Smad3 or Smad4 to stimulate interaction and
activation of PARP-1 auto-poly(ADP-ribosyl)ation. The data
further demonstrate that Smads also bind and activate PARP-2,
albeit much less efficiently. These in vitro experiments also suggest
that purified PARP-1 is more catalytically active than purified
PARP-2, as previously reported [18], and do not allow us to fully
conclude whether the observed ADP-ribosylation of PARP-2 in
the presence of PARP-1 and Smads is due to the activity of PARP-
1 or PARP-2 itself. However, the weak but detectable auto-
poly(ADP-ribosyl)ation of PARP-2 in experiments where PARP-1
was left out and Smad4 was co-incubated (Fig. 4d, lane 15)
suggests that PARP-2 can exhibit genuine ADP-ribosylation
activity, which is assisted by the presence of Smad4. We therefore
conclude that one possible function of the observed protein
complex between Smads, PARP-1 and PARP-2, is that the
binding of Smads regulates or stabilizes the catalytically active
form of these enzymes.
Impact of TGFb on formation of nuclear PARP-1/PARP-2
complexes and their ADP-ribosylation
Based on the previously established association of PARP-1 with
PARP-2 [18], and our evidence that TGFb can induce nuclear
poly(ADP-ribosyl)ation activity ([9] and Fig. 1), we tested whether
TGFb also affects the complex between the two nuclear PARPs.
PLA using PARP-1 and PARP-2 antibodies in HaCaT keratino-
cytes showed exclusively nuclear PARP-1/PARP-2 protein com-
plexes, as expected (Fig. 5a, b). Stimulation of the cells with TGFb
for 0.5 or 1.5 h led to a weak but reproducible increase of nuclear
RCA signals especially at 1.5 h (Fig. 5a, b). As a control, peroxide
treatment enhanced the nuclear PARP-1/PARP-2 complexes
even further (Fig. 5a). Silencing of PARP-1 reduced the number of
complexes significantly (Fig. 5a, b). Silencing PARP-2 also
reduced the number of nuclear complexes, albeit not so efficiently
(Fig. 5a, b). The loss of PLA-positive signals in these experiments
reflected rather well the silencing efficiency, which was approx-
imately 80% for PARP-1 and only 60% for PARP-2 (not shown).
Controls with single PARP-1 or PARP-2 antibodies gave the
anticipated low background signals (Fig. 5a).
The PLA experiments were reproduced using co-immunopre-
cipitation assays in the same cell system, measuring the
endogenous complexes of PARP-1 and PARP-2 in HaCaT cells
(Fig. 5c–e). First, we established the efficient immunoprecipitation
by the PARP-1 antibody (Fig. 5c). Stimulation with TGFb did not
affect at all the efficiency of immunoprecipitation of PARP-1 as
revealed by immunoblot with the same antibody (Fig. 5c). Then,
by immunoprecipitating first PARP-1 or PARP-2 followed by
immunoblotting with the reciprocal antibody gave evidence for the
presence of PARP-1/PARP-2 complexes that were only weakly
affected by TGFb stimulation (Fig. 5c, d), as predicted from the
PLA results (Fig. 5a, b). Use of an isotype-matched control
immunoglobulin (IgG) for the immunoprecipitation gave only low
amounts of co-precipitating proteins (Fig. 5a, b).
We then performed in situ PLA for PARP-1 and PARP-2 ADP-
ribosylation and measured effects of TGFb stimulation (Fig. 6). In
contrast to endogenous Smad3, which showed weak basal levels of
ADP-ribosylation using the PLA (Figure 1), endogenous PARP-1
in the same cells, showed rather high level of RCA signals,
compatible with an active PARP-1 enzyme that was ADP-
ribosylated (Fig. 6a, b). Under the same conditions, PARP-2
Figure 2. PLA of endogenous Smad3 and PARP-1 complexes in HaCaT cells. (a) HaCaT cells were analyzed with PLA using antibodies against
Smad3 and PARP-1 after transfection with control or the indicated specific siRNAs and stimulation with vehicle (-TGFb) or with 2 ng/ml TGFb1 for the
indicated time periods. Specific RCA signals were detected in the nuclei. Cells stimulated with 10 mM hydrogen peroxide for 10 min served as positive
control. PLA with single antibodies against Smad3 or PARP-1 are shown as controls. PLA images are shown as in Fig. 1a. (b) Quantification of the
experiment shown in panel (a) following the histogram method of Fig. 1b. The figure shows a representative experiment from three or more repeats.
doi:10.1371/journal.pone.0103651.g002
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showed weaker than PARP-1 but higher than Smad3 ADP-
ribosylation (Fig. 6c, d). Stimulation with TGFb for 30 min
resulted in measurable enhancement of ADP-ribosylation of
PARP-1 and even more dramatic enhancement of ribosylation
of PARP-2 (Fig. 6b,d). At 90 min after TGFb stimulation ADP-
ribosylation of both proteins decreased and especially for PARP-2
reached the same low levels as in control, unstimulated cells
(Fig. 6b,d). We therefore conclude that PARP-1 and PARP-2
complexes exist in the nucleus, and TGFb either does not
influence or only weakly affects this association, whereas TGFb
prominently promotes complexes of each PARP protein with
Smads, and also promotes ADP-ribosylation of both PARP
enzymes.
Impact of PARP-2 on TGFb-regulated gene expression
Since PARP-2 and PARP-1 reside in the nucleus and we
previously established that PARP-1 affects the transcriptional
activity of Smads [9], we hypothesized that PARP-2 should be
implicated in the same process. To investigate this possibility, we
performed Smad-specific promoter-luciferase assays in cells where
PARP-2 was either overexpressed or silenced by siRNA (Fig. 7a,
b). PARP-2 overexpression led to a weak but reproducible
reduction of the Smad3/Smad4-specific CAGA12-luciferase pro-
moter (Fig. 7a). Conversely, silencing of endogenous PARP-2
almost tripled the response of the same promoter to TGFb
(Fig. 7b). The impact of PARP-2 silencing on the promoter
activity was as pronounced as that of PARP-1 silencing (Fig. 7c).
Finally, silencing of both PARP-1 and PARP-2 had a similar
positive effect on promoter activity (Fig. 7d), however, we never
observed additive or synergistic effects when the two PARPs were
silenced.
The CAGA12-luciferase reporter provides an easy tool to assay
directly the transcriptional activity of Smads. Endogenous
regulatory sequences of various genes that respond to TGFb are
more complex and depend on the activity of Smad complexes,
interacting transcription factors and many cooperating chromatin
modulators and co-activators/co-repressors [3]. For this reason,
the impact of PARP silencing on gene expression in response to
TGFb is more variable, gene-specific and cell context-specific
[9,11]. This is corroborated by our efforts in measuring the impact
of PARP-2 on TGFb target genes after siRNA-mediated silencing
of PARP-2 (Fig. 7g, h). We first established siRNA transfection
conditions that showed specific silencing of PARP-2 without
affecting PARP-1 expression and silencing of PARP-1 without any
impact on PARP-2 expression, as assessed by quantitative RT-
PCR analysis (Fig. 7e, f). Under these conditions we measured the
responsiveness of classic gene targets of TGFb/Smad signaling,
like fibronectin and Smad7 (Fig. 7g, h). PARP-1 silencing
enhanced the response of both genes when measured after 9 h
of TGFb stimulation, while PARP-2 silencing led to more robust
enhancement of the gene response. Silencing of both PARP-1 and
PARP-2 had almost the same effect on gene expression in response
to TGFb as PARP-2 silencing alone (Fig. 7g, h). We therefore
conclude that PARP-2, like PARP-1, can play a negative
regulatory role in TGFb signaling.
PARG interacts with Smads and de-ADP-ribosylates
Smad3
We then shifted our attention to the possibility that Smad ADP-
ribosylation is reversible. First, we asked whether PARG can form
complexes with the three Smads of the TGFb pathway (Fig. 8).
We could not identify a reliable antibody that could detect
endogenous PARG levels in our cells, and thus, we transfected
myc-tagged PARG in 293T cells together with each of the Flag-
tagged Smad2, Smad3 and Smad4 (Fig. 8a). Each one of the three
Smads showed specific co-immunoprecipitation with myc-PARG
(Fig. 8a, left panel). Stimulation of cells with TGFb resulted in a
weak but reproducible enhancement of the complex between
Smad3 and PARG and between Smad4 and PARG (Fig. 8a, right
panel). Co-expression of all three Smads also showed the same
robust co-precipitation of PARG in the same cell system (Fig. 8b).
Immunoprecipitation of endogenous Smad2/3 from 293T cells
resulted in efficient co-precipitation of the transfected myc-PARG,
which was further enhanced after stimulation with TGFb (Fig. 8c).
These experiments demonstrate that PARG has the potential to
form complexes with Smad proteins of the TGFb pathway.
We then investigated how the Smad ADP-ribosylation pattern is
affected by increasing b-NAD levels. We incubated GST-Smad3
together with PARP-1 and radiolabeled b-NAD; pull-down of the
bound proteins followed by electrophoresis and autoradiography
resulted in detectable ADP-ribosylated Smad3 (radioactive band of
the same size as GST-Smad3), as well as bound auto-poly(ADP-
ribosyl)ated PARP-1 appearing as a high molecular weight smear
migrating slower than the core PARP-1 protein (Fig. S2, lane 1).
We then used a constant amount of radioactive b-NAD and
increasing concentrations of unlabeled b-NAD (Fig. S2, lanes 1–4).
We observed ADP-ribosylation of GST-Smad3 under all b-NAD
concentrations. Increasing the concentration of unlabeled b-NAD
enhanced ADP-ribosylation of GST-Smad3 and PARP-1 (Fig. S2,
lane 2), but at higher concentrations the high amount of unlabeled
b-NAD diluted the radiolabeled tracer and we recorded a loss in
signal (Fig. S2, lanes 3, 4). As expected, PARP-1 shifted upwards in
size with increasing amounts of b-NAD (Fig. S2, top smear, lanes
2–3), illustrating the ability of PARP-1 to become poly(ADP-
ribosyl)ated at one or several sites. At the highest concentrations of
non-radiolabeled b-NAD, 32P-ADP-ribosylation signals were
competed out from PARP-1 to a large extent, due to the dilution
effect mentioned above. In contrast to the smear of auto-
poly(ADP-ribosyl)ated PARP-1 there was no shift in size of
ADP-ribosylated GST-Smad3 despite the increased concentra-
tions of b-NAD, only competition and loss of the sharp
radiolabeled GST-Smad3 protein band could be observed (Fig.
S2). This suggests that, under in vitro conditions, PARP-1 mainly
oligo(ADP-ribosyl)ates GST-Smad3 at one or a limited number of
sites since excess of b-NAD fails to reveal high molecular size
smears.
Next, we tested whether PARG could de-ADP-ribosylate
Smad3 by first performing ADP-ribosylation reactions with
PARP-1 and GST-Smad3 as substrates, and then incubating with
recombinant PARG (Fig. 8d). The reaction with PARG efficiently
removed ADP-ribosylation from GST-Smad3 in a dose-dependent
manner. However, the radioactive signal could not be completely
Figure 3. PLA of endogenous Smad2/3 and PARP-2 complexes in HaCaT cells. (a) HaCaT cells were analyzed with PLA using antibodies
against Smad2/3 and PARP-2 after transfection with control or the indicated specific siRNAs and stimulation with vehicle (-TGFb) or with 2 ng/ml
TGFb1 for the indicated time periods. Specific RCA signals were detected in the nuclei. Cells stimulated with 10 mM hydrogen peroxide for 10 min
served as positive control. PLA with single antibodies against Smad2/3 or PARP-2 are shown as controls. PLA images are shown as in Fig. 1a. (b)
Quantification of the experiment shown in panel (a) following the histogram method of Fig. 1b. The figure shows a representative experiment from
three or more repeats.
doi:10.1371/journal.pone.0103651.g003
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Figure 4. TGFb induces formation of endogenous complexes between Smads and PARP-1/2 in HaCaT cells. (a) Immunoprecipitation of
Flag-Smad2/3/4 followed by immunoblotting for PARP-1 and PARP-2 in cell lysates of transiently transfected HEK-293T cells with the indicated
plasmids and after stimulation with vehicle (-TGFb) or 5 ng/ml TGFb1 for 30 min. Expression levels of all transfected proteins and endogenous PARP-1
and PARP-2 are shown in the total cell lysate (TCL) immunoblot of the HEK 293T cells. PARP-1 immunoblot also serves as protein loading control. Stars
mark non-specific protein bands. (b) Immunoprecipitation of Smad2/3 followed by immunoblotting for PARP-1, PARP-2, Smad2/3 and Smad4 in
HaCaT cells stimulated with vehicle (-TGFb) or with 5 ng/ml TGFb1 for 30 min. Negative control immunoprecipitation using non-specific IgG is
shown. TCL shows the levels of endogenous proteins before immunoprecipitation. PARP-1 immunoblot also serves as protein loading control and C-
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removed from the core GST-Smad3 protein species, which
probably reflects the inability of PARG to cleave the last ADP-
ribose unit, which is coupled to the protein substrate [21]. In
contrast, the larger sized smears, most likely corresponding to
poly(ADP-ribosyl)ated PARP-1, were efficiently removed by
PARG. In summary, the glycohydrolase PARG can effectively
process the added poly-/oligo(ADP-ribose) units from both GST-
terminal phospho-Smad2 (p-Smad2) serves as control for the efficiency of stimulation of TGFb signaling. (c) Immunoprecipitation of Smad2/3
followed by immunoblotting for PARP-1, PARP-2, Smad2/3 and Smad4 in HaCaT cells transfected with the indicated siRNAs and stimulated with 5 ng/
ml TGFb1 for 30 min or not (-TGFb). Efficiency of knockdown of PARP-1 and PARP-2, total Smad levels, phospho-Smad2 levels and protein loading (a-
tubulin) controls can be seen in the TCL. (d) In vitro PARylation assay after glutathion-pulldown of control GST protein or GST-Smad3, truncated
mutant of GST-Smad3 (DMH2) and GST-Smad4 in the presence of recombinant PARP-1 and/or recombinant PARP-2 as indicated. A star (weak signal)
indicates the position of PARP-2 in addition to the arrow. A longer exposure of the autoradiogram around the migrating position of PARP-2 is shown
at the bottom. Note the position of ADP-ribosylated Smad proteins that migrate at the size of the core non-ADP-ribosylated proteins. The input
amounts of recombinant proteins were calculated based on staining of test SDS-PAGE with CBB as shown in Fig. S1. The figure shows results from
representative experiments that were repeated at least twice.
doi:10.1371/journal.pone.0103651.g004
Figure 5. Analysis of endogenous PARP-1 and PARP-2 complexes in HaCaT cells. (a) HaCaT cells were analyzed with PLA using antibodies
against PARP-1 and PARP-2 after transfection with control or the indicated specific siRNAs and stimulation with vehicle (-TGFb) or with 2 ng/ml TGFb1
for the indicated time periods. Specific RCA signals were detected in the nuclei. Cells stimulated with 10 mM hydrogen peroxide for 10 min served as
positive control. PLA with single antibodies against PARP-1 or PARP-2 are shown as controls. PLA images are shown as in Fig. 1a. (b) Quantification of
the experiment shown in panel (a) following the histogram method of Fig. 1b. Panels a–b show a representative experiment from three or more
repeats. (c) Immunoprecipitation of PARP-1 followed by immunoblotting for PARP-1 in HaCaT cells stimulated with vehicle (-TGFb) or with 5 ng/ml
TGFb1 for 30 min. Negative control immunoprecipitation using non-specific IgG is shown. TCL shows the levels of endogenous proteins before
immunoprecipitation. C-terminal phospho-Smad2 (p-Smad2) serves as control for the efficiency of stimulation of TGFb signaling and a-tubulin as
protein loading control. (d) Immunoprecipitation of PARP-1 followed by immunoblotting for PARP-1 and PARP-2 in HaCaT cells stimulated with
vehicle (-TGFb) or with 5 ng/ml TGFb1 for 30 min. Negative control immunoprecipitation using non-specific IgG is shown. TCL shows the levels of
endogenous proteins before immunoprecipitation. PARP-1 immunoblot also serves as protein loading control and C-terminal phospho-Smad2 (p-
Smad2) serves as control for the efficiency of stimulation of TGFb signaling. (e) Reciprocal immunoprecipitation of PARP-2 followed by
immunoblotting for PARP-1 and PARP-2 in HaCaT cells stimulated with vehicle (-TGFb) or with 5 ng/ml TGFb1 for 30 min. Negative control
immunoprecipitation using non-specific IgG is shown. TCL shows the levels of endogenous proteins before immunoprecipitation. C-terminal
phospho-Smad2 (p-Smad2) serves as control for the efficiency of stimulation of TGFb signaling and a-tubulin as protein loading control. Panels c–e
show results from representative experiments that were repeated at least twice.
doi:10.1371/journal.pone.0103651.g005
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Smad3 and PARP-1, but fails to act as a mono(ADP-ribose)
hydrolase as predicted from previous studies [22].
Endogenous PARP-1 and PARG have opposing roles on
TGFb-induced gene expression
The evidence that PARG can de-ADP-ribosylate Smad3 in
vitro made us design experiments to test for possible effects that
endogenous PARG has on signaling. We compared TGFb-
induced gene expression after performing knock-down of either
endogenous PARP-1 or PARG. As shown previously [9], depleting
PARP-1 led to a significant elevation of TGFb-induced expression
of endogenous fibronectin (FN1) and PAI-1 mRNA after 9 h of
stimulation (Fig. 9a, b). Knockdown of endogenous PARP-1 was
verified at the mRNA level (Fig. 9c). Interestingly, depleting
PARG had the opposite effect on mRNA accumulation of these
two genes; the induction of either fibronectin or PAI-1 expression
by 9 h stimulation with TGFb was significantly reduced when
PARG expression was silenced (Fig. 9d, e). Knockdown efficiency
of endogenous PARG was determined by RT-PCR (Fig. 9f).
We also checked whether the hampered TGFb-mediated gene
induction seen after silencing PARG expression also had an
impact on the corresponding induced protein levels. Indeed, when
PARG expression was silenced, the fibronectin and PAI-1 protein
levels were induced to lower levels than those seen in control cells
after 9 and 24 h of TGFb stimulation (Fig. S3). The difference at
9 h of stimulation was most noticeable, while after 24 h the
differences were reproducible but smaller. No major effects on
TGFb-induced phosphorylation of Smad2 were found that could
account for the changes seen on downstream fibronectin and PAI-
1 expression (Fig. S3). This suggests that the observed effects of
endogenous PARG silencing more likely reflect regulation at the
transcriptional level.
Silencing of PARP-1 rescues the PARG-mediated
reduction of TGFb signaling
Since there are several factors that possess ADP-ribosylating
capacity in the cell [15], and since PARG might also act through
an ADP-ribosylation-independent mechanism, it was important to
test if the gene expression effects, recorded by loss of PARG, were
dependent on PARP-1. We designed rescue experiments where we
tested if the perturbed induction of fibronectin and PAI-1 mRNA
by TGFb under PARG silencing conditions could be relieved by
simultaneous silencing of PARP-1. We knocked-down PARG
alone or in combination with PARP-1 using the corresponding
siRNAs and stimulated cells with TGFb for 24 h (Fig. 10a, b).
Depleting PARG mRNA had again a reducing effect on TGFb-
induced expression of both fibronectin and PAI-1 mRNA,
although the effects were significantly less after this longer (24 h)
Figure 6. PLA of endogenous PARP-1 and PARP-2 ADP-ribosylation after TGFb stimulation in HaCaT cells. (a, c) HaCaT cells were
analyzed with PLA using antibodies against PARP-1 and PAR chains (a) or antibodies against PARP-2 and PAR (c) after stimulation with vehicle (0 min)
or with 2 ng/ml TGFb1 for the indicated time periods. Specific RCA signals were detected in the nuclei. PLA with single antibodies against PARP-1 or
PAR are shown as controls. PLA images are shown as in Fig. 1a. (b, d) Quantification of the experiments shown in panels (a, c) following the
histogram method of Fig. 1b. The figure shows a representative experiment from three or more repeats.
doi:10.1371/journal.pone.0103651.g006
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Figure 7. Regulation of gene expression by PARP-1 and PARP-2 during TGFb signaling. (a) CAGA12 promoter luciferase assay in HaCaT
cells transiently transfected with pBC-vector (pBC-v) and pBC-PARP-2 and stimulated (grey bars) or not (white bars) with 5 ng/ml TGFb1 for 24 h.
Average values with standard errors of luciferase activity normalized to the corresponding co-transfected b-galactosidase activity from triplicate
determinations are shown based on a representative single experiment. (b–d) CAGA12 promoter luciferase assays were performed as in panel (a) in
HaCaT cells transiently transfected with the indicated siRNAs 48 h prior to stimulations with TGFb1. Stars (panels a–d) indicate statistical significance
relative to the Control condition stimulated with TGFb1, p,0.05. (e, f) Quantitative real-time RT-PCR assays for PARP-1 (e, black bars) and PARP-2 (f,
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stimulation. The combination of PARG and PARP-1 siRNA could
fully rescue the signal back to control levels (Fig. 10a, b). However,
it did not elevate signaling beyond control levels (Fig. 10a, b), as
seen when PARP-1 knockdown was performed alone (Fig. 10b, c).
This suggests that PARP-1 accounts for a large part of the changes
seen on TGFb signaling after PARG knockdown; however, it is
possible that other ribosylating enzymes are involved. In summary,
these data establish a role of PARG as a positive mediator, or a
permissive factor, that controls the transcriptional responses to
TGFb signaling.
Discussion
The recent demonstration that TGFb induces nuclear ADP-
ribosylation, that Smad proteins associate directly with PARP-1,
and that PARP-1 has regulatory impact on the functional output
of the TGFb pathway [9,10,11], prompted us to investigate deeper
TGFb-induced ADP-ribosylation and the role of two other known
regulators of ADP-ribosylation, PARP-2 and PARG.
By using antibodies against Smad3 and poly(ADP-ribose)
chains, we managed to set up a specific assay that allowed us to
study Smad3 ADP-ribosylation in a timely fashion. We have
previously been unable to successfully perform such analysis using
immunoprecipitation assays. Interestingly, we found that TGFb
induced ADP-ribosylation of Smad3 rapidly. Specific PLA-positive
RCAs were detectable already after 5 min, peaked at 10 min and
were reduced to lower levels after 40–90 min (Fig. 1). This
suggests that ADP-ribosylation of Smad3 is likely regulating an
early nuclear event after TGFb stimulation. We have previously
reported that PARP-1 regulates Smad3/4 binding to promoter
DNA by ADP-ribosylating the MH1 domain [9,10,11]. This
observation would fit well with the timing of ADP-ribosylation,
since Smads enter the nucleus and interact with promoters early
on after TGFb stimulation. Higher resolution microscopy could
reveal the nuclear locations of ADP-ribosylated Smad3 and
chromatin organization analysis may provide new ideas about
possible functions of this molecular modification that takes place
during the first minutes of TGFb signaling. PARP-1 may prevent
binding of Smads that are not yet attached to the DNA or may
facilitate detachment of Smads that are already bound to
promoters, whereas TGFb-mediated activation of PARP-1 may
lead to ADP-ribosylation of other proteins associated with
transcription, such as transcription factors, polymerases, or
histones. These interesting open questions need to be further
investigated.
The analysis of PARP2 as regulator of TGFb/Smad signaling
was motivated by the current understanding that PARP-2 makes
complexes with and functions in close association with PARP-1
[17]. Our results have shown that Smads form complexes with
PARP-2 in the cell nucleus (Fig. 2–4), and that Smads may
enhance the ADP-ribosylation of PARP-2 (Fig. 4d). We have not
been able to identify unique functions of Smad/PARP-2 versus
Smad/PARP-1 complexes. On the other hand, these complexes
form and are not necessarily dependent on each other, i.e. Smad/
PARP-1 complexes to a large approximation do not depend on
PARP-2 and Smad/PARP-2 complexes do not depend on PARP-
1 (Fig. 2–4). However, the complexes are not entirely independent
from each other as seen in PLA experiments (Fig. 2, 3), suggesting
that the complexes may become more stable when PARP-1,
PARP-2 and Smads come together. Cooperation of the Smad/
PARP-1/2 complexes at the level of enzymatic activity is also
supported by these experiments. In addition, PARP-2 seems to
negatively regulate the direct, Smad-dependent transcriptional
output of TGFb signaling, similar to PARP-1 (Fig. 7). We
therefore propose that PARP-2 functions together with PARP-1
to negatively regulate nuclear and transcription-related functions
of the Smad complex (Fig. 10c).
The ability of PARP-2 to interact physically with PARP-1 has
been previously established [18], and the functional interplay
between these two PARP family members has been well
established in vitro in cell models and in vivo in mice, and under
different physiological conditions [17]. Here, we have confirmed
this physical association using the PLA technique [26], which
provides us with the capacity to visualize the location of the PARP-
1/PARP-2 complexes and also allows us to measure rather
accurately the abundance of such complexes (Fig. 5). As expected,
the PARP-1/PARP-2 complexes could be localized only in cell
nuclei (Fig. 5a), and PLA allowed us to establish that these
complexes are only weakly enhanced or stabilized upon relatively
short (0.5–1.5 h) stimulation with TGFb (Fig. 5b). This change is,
however, compatible with the time frame of association of Smad
proteins of the TGFb pathway with PARP-1 and PARP-2 (Fig. 2,
3). Thus, the data suggest that when Smad complexes enter the
nucleus in response to TGFb signaling, they meet and associate
with PARP-1 and PARP-2 that are already in complex with each
other.
Another interesting corollary of the association between Smads
and PARPs is the possible regulation of the enzymatic activity and
resulting ADP-ribosylation catalyzed by the PARPs (Fig. 1, 4d).
Previous reports demonstrated that TGFb enhances ADP-
ribosylation of nuclear proteins and of PARP-1 itself in cells
[9,10,11]. The time frame of Smad3 ADP-ribosylation falls well
inside the time window when Smads associate with PARP-1 and
PARP-2 in the nucleus (Fig. 2, 3). Furthermore, the in vitro
experiments have revealed that both Smad3 and Smad4 are
capable of co-precipitating with activated poly(ADP-ribosyl)ated
PARP-2 and PARP-1 (Fig. 4d). In addition, the experiments
suggest that PARP-1 is required for the more effective ADP-
ribosylation of PARP-2 itself. However, we cannot preclude that
this is an effect due to the quality of our purified PARP-2 protein.
PLA experiments aiming at measuring PARP-1 and PARP-2
ADP-ribosylation corroborate the above conclusion as TGFb
appeared to enhance ADP-ribosylation of both enzymes, and this
was much more dramatic in the case of PARP-2 (Fig. 6).
Interestingly, the effect of TGFb on PARP-1 or PARP-2 ADP-
ribosylation, as measured by PLA, coincided with the formation of
Smad3-PARP-1/2 complexes (Fig. 2, 3). This suggests the
possibility that as nuclear Smad complexes associate with PARP-
1 and PARP-2, they may also enhance the ADP-ribosylation of
these two proteins. Whether enhancement of PARP-1 and PARP-
2 ADP-ribosylation by TGFb was mediated by Smad3, or by the
association of Smad3 with the PARP enzymes, could not yet been
grey bars) in HaCaT cells after transient transfection with control and specific siRNAs. The specific mRNA amounts were normalized to the expression
level of the housekeeping gene GAPDH and are expressed as relative fold-differences. Average values from triplicate determinations are shown with
standard deviations as error bars. (g, h) Real-time RT-PCR analysis of endogenous fibronectin (panel g) and Smad7 (panel h) mRNAs normalized to the
corresponding GAPDH mRNA from human HaCaT cells transfected with the indicated siRNAs and left unstimulated (0 h) or were stimulated with
2 ng/ml TGFb1 for 9 h. Average values from triplicate determinations and the corresponding standard errors are graphed. Stars (panels g, h) show
statistical significance relative to the siControl condition stimulated with TGFb1, p,0.05. The figure shows representative experiments from four or
more repeats.
doi:10.1371/journal.pone.0103651.g007
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Figure 8. PARG forms complexes with Smad proteins and de-ADP-ribosylates Smad3. (a) Immunoprecipitation of Flag-Smad2, Flag-
Smad3 or Flag-Smad4 followed by immunoblotting for myc-PARG in cell lysates of transiently transfected 293T cells with the indicated plasmids and
after stimulation with vehicle (-TGFb, left panel) or 5 ng/ml TGFb1 for 30 min (right panel). Expression levels of all transfected proteins are shown in
the TCL immunoblot of the 293T cells. (b) Immunoprecipitation of Flag-Smad2/3/4 followed by immunoblotting for myc-PARG in cell lysates of
transiently transfected 293T cells with the indicated plasmids and in the absence of stimulation with TGFb. Expression levels of all transfected
proteins are shown in the TCL immunoblot of the 293T cells. a-Tubulin immunoblot serves as protein loading control. Stars mark non-specific protein
bands. (c) Immunoprecipitation of endogenous Smad2/3 followed by immunoblotting for transfected myc-PARG in 293T cells stimulated with vehicle
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(-TGFb) or with 5 ng/ml TGFb1 for 30 min. Negative control immunoprecipitation using non-specific IgG is shown. TCL shows the levels of
endogenous Smad2/3 proteins and transfected myc-PARG before immunoprecipitation. Smad2/3 immunoblot also serves as protein loading control.
(d) In vitro de-ADP-ribosylation assay of Smad3 using PARG. GST-Smad3 was first ADP-ribosylated using recombinant PARP-1. The proteins were
pulled-down and washed, prior to reconstitution with PARG reaction buffer and increasing amounts of recombinant PARG (shown as milli-units (mU)
of enzymatic activity). The ADP-ribosylated proteins are shown in the autoradiogram along with the CBB-stained input GST-Smad3 levels. Panels a–c
show results from representative experiments that were repeated at least twice and panel d shows results from representative experiments that were
repeated at least three times.
doi:10.1371/journal.pone.0103651.g008
Figure 9. PARG regulates transcriptional responses to TGFb. (a–c) Real-time RT-PCR analysis of endogenous fibronectin (FN1) (a), PAI-1 (b) and
control PARP-1 (c) mRNAs in HaCaT cells transiently transfected with the indicated siRNAs (bottom of panel c) prior to stimulation (or not) with 5 ng/
ml TGFb1 for 9 h. The data are graphed as in Fig. 7g, h. (d–f) Real-time RT-PCR analysis of endogenous fibronectin (FN1) (d), PAI-1 (e) and control PARG
(f) mRNAs in HaCaT cells transiently transfected with the indicated siRNAs (bottom of panel f) prior to stimulation (or not) with 5 ng/ml TGFb1 for 9 h.
The data are graphed as in Fig. 7g, h. Stars (panels b–g) indicate statistical significance, p,0.05. The figure shows representative experiments from
four or more repeats.
doi:10.1371/journal.pone.0103651.g009
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confirmed at the cellular level due to the relative failure of anti-
PAR PLA after transfection with siRNAs or plasmids expressing
cDNAs. Thus, the mechanism whereby Smads regulate ADP-
ribosylation of PARPs requires deeper investigation. One possi-
bility is that upon binding, Smads activate the catalytic activity of
PARP-1 and PARP-2; alternatively, Smad binding to PARPs,
exposes more effectively the auto-modification domain of PARPs,
thus allowing more robust and stable ADP-ribosylation of the
protein substrate. To explain these mechanistic details, deeper
biochemical and structural studies are needed.
We have also focused our attention on the pattern of Smad3
ADP-ribosylation in vitro and on the action of the enzyme PARG
that cleaves off PAR chains from modified proteins [21]. PARG
exhibited robust complex formation with Smads of the TGFb
pathway (Fig. 8). The lack of a reliable antibody did not allow us
to measure fully endogenous complexes between PARG and
Smads. However, despite transfection of cells with exogenous
PARG, we could observe that TGFb stimulation promoted the
association of endogenous Smad2/3 with PARG (Fig. 8c). Using
recombinant PARG enzyme we then demonstrated that PARG is
capable of de-ADP-ribosylating Smad3 (Fig. 8d). Furthermore,
increasing the b-NAD levels in the in vitro ribosylation assays
showed that Smad3 is primarily oligo(ADP-ribosyl)ated by PARP-
1 (Fig. S2). This is in contrast to PARP-1 itself that is clearly
poly(ADP-ribosyl)ated. Development of new technology that can
more effectively measure the degree of polymerization of ADP-
ribose during protein ADP-ribosylation and de-ADP-ribosylation
will be essential to resolve questions regarding poly(ADP-ribose)
chain length and function in an unambiguous manner.
Our observations support a model in which PARP-1, PARP-2
and PARG regulate ADP-ribosylation of Smad3 and the flow of
Smad signaling (Fig. 1, 7, 8). While depletion of PARP-1 or
PARP-2 led to enhancement of the transcriptional readout of
TGFb signaling (Fig. 7), depletion of PARG showed the opposite
effect and significantly suppressed the amplitude of the TGFb
transcriptional response (Fig. 9). This evidence suggests that
optimal and average transcriptional responses to TGFb/Smad
signaling are balanced by the action of the two opposing
enzymatic activities, the ADP-ribosyl-transferases (PARP-1/2)
and the ADP-ribosyl glycohydrolase PARG. Since we could not
achieve complete removal of the ADP-ribose chains from Smad3
after prolonged incubation with PARG (Fig. 8d), we propose that
additional enzymes may act in concert with PARG to completely
de-ADP-ribosylate Smad3. Such proteins may be members of the
ARH and macrodomain-containing protein families [22]. PARG
has been shown to co-localize with PARP-1 along genomic sites in
Figure 10. Regulation of Smad signaling by PARG and PARP-1. (a, b) Real-time RT-PCR analysis of endogenous fibronectin (FN1) (a) and PAI-1
(b) mRNAs in HaCaT cells transiently transfected with the indicated siRNAs (bottom of panel b) prior to stimulation (or not) with 5 ng/ml TGFb1 for
24 h. The data are graphed as in Fig. 7g, h. Stars (panels a, b) indicate statistical significance, p,0.05. The figure shows representative experiments
from four or more repeats. (c) A model depicting TGFb dimeric ligand that activates its cell surface type II (RII) and type I (RI) receptors, which
phosphorylates Smad2 and Smad3, leading to oligomerization of Smad2, Smad3 and Smad4 into trimeric complexes. Smad oligomers enter the
nucleus via nuclear pores and associate with chromatin in order to regulate transcription of target genes such as Smad7, fibronectin (FN1) and PAI-1.
Nuclear PARP-1 and PARP-2 in complex associate with the Smad oligomer. For simplicity distinct complexes between Smads and PARP-1 and Smads
and PARP-2 are not shown but their presence is supported by the experimental evidence. PARP-1/PARP-2 use NAD and oligo(ADP-ribosyl)ate Smad3
and Smad4 (ADP-ribose chains in red) and assist dissociation of Smads from DNA (as demonstrated in ref. [9,10,11]). PARG associates with ADP-ribose
chains on the Smad complex and removes ADP-ribose units (ADPr) possibly generating mono(ADP-ribosyl)ated Smads (not shown). PARG therefore
promotes Smad association with DNA and is required for optimal gene expression in response to TGFb.
doi:10.1371/journal.pone.0103651.g010
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mammalian cells [24]. This suggests that upon entry of the Smad
complex to the nucleus and formation of higher order complexes
with PARP-1 and PARP-2, PARG may also be available for
incorporation into such complexes in order to regulate quantita-
tively the degree of Smad ADP-ribosylation (Fig. 10c). Thus,
nuclear PARG may constantly monitor the extent of Smad ADP-
ribosylation by PARP-1/2 and provide dynamic control of the
Smad-chromatin association/dissociation process (Fig. 10c). Al-
ternatively, PARG may play a more important role at the onset of
transcription in response to Smad signaling, thus guaranteeing the
establishment of chromatin-bound Smad complexes. If this
scenario stands true, the action of PARG may precede the action
of PARP-1 during the time-dependent trajectory of Smad
complexes along the chromatin.
In addition, it is worth discussing the fact that evidence from
different cell systems demonstrated that PARP-1 can act either as a
negative regulator of physiological responses to TGFb, as is the
case in epithelial cells (keratinocytes and mammary cells) [9] and
CD4-positive T cells [10], or as a positive regulator of TGFb
responses, as is the case in vascular smooth muscle cells [11]. Our
new data on the functional role of PARP-2 and PARG during
regulation of TGFb-mediated gene expression in keratinocytes
supports the negative role of PARP-1 and PARP-2 and the positive
role of PARG on such cellular responses (Fig. 7, 9, 10). It will be of
importance to explain the molecular mechanism behind this
apparent cell context-dependency. All studies so far agree that
PARP-1 ADP-ribosylates Smad3 [9,10,11], and our new evidence
suggests that Smad3 can also be de-ADP-ribosylated (Fig. 8). We
therefore propose that depending on the cell type, the chromatin
configuration on various genes that are destined to respond to
TGFb/Smad signaling interpret the molecular signal of Smad3
ADP-ribosylation and de-ADP-ribosylation in distinct ways. This
is compatible with the positive or negative regulatory effects
PARP-1 has on transcription of various genes [12], and also
compatible with the current understanding on how Smad
complexes regulate transcription, by reading the pre-existing code
of local chromatin and thus providing differential gene regulation
according to cell type, developmental stage and crosstalk with
other signaling inputs that a given cell receives [1,2,3].
In conclusion, the new evidence that implicates PARP1/2 and
PARG as regulators of Smad function and overall transcriptional
control by the TGFb pathway (Fig. 10c), opens a new window of
understanding of the molecular connections that exist between
PARP family members and the central players of a major
developmental signaling pathway. Since PARG silencing blocks
basic TGFb signaling responses, development of specific PARG
inhibitors may provide a potential tool that could simultaneously
modulate PARG and TGFb activity during various diseases such
as cancer [21,27]. The present investigation opens the way for
exploring such novel possibilities in basic biology and in the
targeted therapy of disease.
Materials and Methods
Cell culture and transfections
Human embryonic kidney 293T cells were cultured according
to protocols from the American Type Culture Collection (LGC
Standards AB, Bora˚s, Sweden). Human immortalized keratino-
cytes HaCaT were obtained and cultured as described before [28].
Transient transfections of cells were done using calcium phosphate
[29] and Fugene HD (Roche Diagnostics Scandinavia AB,
Bromma, Sweden) according to their standard protocols. Short-
interfering RNA (siRNA) oligoneucleotide pools were purchased
from Dharmacon/Thermo Fischer Scientific Inc. (Waltham, MA,
USA). Transfection of siRNA oligonucleotides (10–25 nM)
targeting human PARP-1 (Dharmacon ONTARGETplus
SMARTpool L-006656-00), human PARP-2 (Dharmacon ON-
TARGETplus SMARTpool L-010127-02), human PARG (Dhar-
macon ON-TARGETplus SMARTpool L-011488-00) or non-
targeting control (Dharmacon ONTARGETplus Non-targeting
pool D-001810-10), was performed using siLentfect (Bio-Rad
Laboratories AB, Solna, Sweden) transfection reagent. The cells
were transfected a single time for 36 or 48 h and cultured in
DMEM containing 3%, 5% or 10% fetal bovine serum prior to
stimulations and cell-based assays. The cells were stimulated with
TGFb and processed for RNA isolation, immunoblotting or
microscopy analysis after applying PLA.
Plasmids and other reagents
The mammalian expression vectors pCDNA3, pCDNA3-Flag-
Smad2, pCDNA3-Flag-Smad3, pCDNA3-Flag-Smad4 and
pDEF3-Flag-Smad2, pDEF3-Flag-Smad3, pDEF3-Flag-Smad4
have been described [29,30]. pGEX vectors encoding GST-
Smad3, GST-Smad4 and GST-Smad3DMH2, have been de-
scribed [29,31]. pCDNA3.1-Myc-PARP-1 encoding Myc-tagged
wild-type PARP-1, was previously described [32]. The pBC-
mPARP2 and the control pBC vectors were kind gifts from Vale´rie
Schreiber [18]. The pCS2-myc-PARG and control pCS2 vectors
were kind gifts from Paola Caiafa [33]. The CAGA12 reporter
pCAGA12-MLP-luc, pCMV-b-gal and pEGFP-N3, have been
described before [29,30].
Recombinant mature TGFb1 was bought from PeproTech EC
Ltd. (London, UK) and Biosource Inc. (Camarillo, CA, USA). The
TGFb1 isoform was used throughout this study and is referred to
as TGFb. The b-NAD was bought from Sigma-Aldrich Sweden
AB (Stockholm, Sweden), H2O2 and Coomassie brilliant blue
R250 (CBB) from MERCK KGaA (Darmstadt, Germany), high
purity recombinant PARP-1, PARP-2 and PARG (20,000 U/mg,
0.1 mg/ml) isolated from insect cells after baculoviral infection
were bought from Axxora, LLC/ENZO Life Sciences, GmbH
(Lo¨rrach, Germany).
Antibodies
Mouse monoclonal anti-Flag (M2 and M5) and anti-fibronectin
(F3648) antibodies were from Sigma-Aldrich Sweden AB (Stock-
holm, Sweden); rabbit polyclonal anti-PARP2 from Active Motif
(La Hulpe, Belgium); mouse monoclonal anti-PARP-1, anti-PAI-1
(plasminogen activator inhibitor 1), anti-Smad2/3 and rabbit
polyclonal anti-PAR (used for PLA with mouse anti-PARP-1) from
BD Pharmingen/Transduction Laboratories (BD Biosciences,
Stockholm, Sweden); mouse monoclonal anti-Smad4 (B8), mouse
monoclonal anti-Myc (9E10) and anti-a-tubulin from Santa Cruz
Inc. (Santa Cruz, CA, USA); rabbit polyclonal anti-Smad3 from
Epitomics (Burlingame, CA, USA); mouse monoclonal anti-PAR
(used for PLA with rabbit anti-PARP-2 and rabbit anti-Smad3)
from Axxora, LLC/ENZO Life Sciences, GmbH (Lo¨rrach,
Germany); and rabbit polyclonal anti-phospho-Smad2 was pro-
duced in house [21,27].
Proximity Ligation Assay
HaCaT cells were permeabilized with 0.2% Triton X-100 in
PBS for 10 min at room temperature (RT) with agitation prior to
double wash with 16PBS for 5 min with agitation. The cells were
incubated with Duolink II blocking solution for 1 h at RT with
agitation (80 rpm), which was removed prior to adding primary
antibodies. The antibodies were diluted in Duolink II antibody
diluent 1:100 and the cells were incubated overnight at 4uC, with
agitation (80 rpm). The cells were washed 363 min with Buffer A
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(Duolink, Olink Bioscience, Uppsala Sweden) prior to adding
secondary probes (Duolink II), diluted with Duolink II antibody
diluent 1:5. The cells were further incubated 2 h at 37uC with
agitation (80 rpm), prior to 363 min wash with Buffer A. Duolink
Ligation stock was diluted 1:5 in double distilled water and
Duolink Ligase was added to the ligation solution from the
previous step at a 1:40 dilution under vortex condition. Ligation
solution was added to each sample and the slides were incubated
in a pre-heated humidity chamber for 30 min at 37uC. The slides
were washed with Buffer A for 262 min under gentle agitation
and the wash solution was tapped off after the last washing.
Duolink Amplification stock was diluted 1:5 in double distilled
water and Ligation solution was tapped off from the slides.
Duolink Polymerase was added to the Amplification solution at a
1:80 dilution under vortex condition. Amplification solution was
added to each sample and the slides were incubated in a pre-
heated humidity chamber for 90 min at 37uC and the slides were
rinsed once with Buffer A. Phallodin 488 (1:40) and Hoechst
(1:500) (both purchased from Sigma-Aldrich Sweden AB, Stock-
holm, Sweden), were added to phosphate buffered saline (PBS)
and the slides were incubated at RT for 10 min prior to 2610 min
wash with Buffer B (Duolink II). Slides were rinsed with double
distilled water and mounted with Slowfade (Invitrogen/Life
Technologies-Thermo Fischer Scientific Inc., Stockholm, Sweden)
mounting medium. Pictures were taken with a Zeiss AxioPlan2
epi-microscope. The DuolinkImageTool software (Olink Biosci-
ence, Uppsala Sweden) was used for image analysis and signal
quantification. Due to the antibody species specificity requirement
in PLA assays, a rabbit anti-Smad3 antibody was combined with a
mouse anti-PAR antibody (Fig. 1). The same rabbit anti-Smad3
antibody was combined with a mouse anti-PARP-1 antibody
(Fig. 2), whereas a mouse anti-Smad2/3 antibody was combined
with a rabbit anti-PARP-2 antibody (Fig. 3). The mouse anti-
PARP-1 antibody was combined with the rabbit anti-PARP-2
antibody (Fig. 5), the mouse anti-PARP-1 antibody was combined
with the rabbit anti-PAR antibody (Fig. 6), and the rabbit anti-
PARP-2 antibody was combined with the mouse anti-PAR
antibody (Fig. 6). It is therefore obvious that for some of the
PLA assays it was technically impossible to compare directly the
same antibodies (e.g. Smad3 against the various PARPs or PAR).
Co-immunoprecipitation and immunoblotting assays
293T or HaCaT cells were transfected with constructs, left
without transfection and/or treated as explained in the figures.
Total proteins from the cells were extracted in Nonidet-P 40 (NP-
40) lysis buffer (20 mM Tris-HCl [pH 8.0], 1% NP-40, 150 mM
NaCl, 2 mM EDTA, and complete protease inhibitor cocktail
from Roche Diagnostics Scandinavia AB, Bromma, Sweden) and
subjected to SDS-PAGE and analyzed by immunoblotting, as
described previously [28]. Lysates were heated at 95uC for 5 min
prior to SDS-PAGE. Alternatively, cells were lysed in the above
NP-40 lysis buffer 36–48 h after transfection or after the indicated
times of TGFb stimulation. The indicated proteins were immu-
noprecipitated, and after three washes in lysis buffer, including one
wash in lysis buffer containing 0.5 M NaCl, the immunocomplexes
were resolved by SDS-PAGE and immunoblotted with antibodies,
as described in the figure legends.
In vitro ADP-ribosylation assays
Newly prepared GST-vector or GST-Smad proteins were kept
on glutathione beads and incubated in 100 ml PARP-1 reaction
buffer (100 mM Tris-HCl [pH 8], 10 mM MgCl2, 1 mM
dithiothreitol), with or without 100 ng PARP-1 or 100 ng
PARP-2. Then, 80 nM b-NAD and 20 nM 32P-b-NAD were
added and the samples were incubated for 30 min at 37uC while
shaking. For reactions with excess cold NAD, instead of 80 nM b-
NAD, 180, 480 or 980 nM b-NAD were included in separate
reactions, reaching the total concentration of cold plus radioactive
b-NAD to 200, 500 and 1,000 nM respectively (Fig. S1). PARG
incubations were performed in PARG reaction buffer containing
(100 mM Tris-HCl, pH 8.0, 10 mM MgCl2 and 1 mM dithio-
threitol) with and without PARG. At the end of each reaction,
beads with GST fusion proteins were collected via centrifugation,
followed by a quick double wash in ice-cold NP-40 lysis buffer to
remove excess radioactive b-NAD. Samples were then heated for
4 min at 95uC in sample buffer and subjected to SDS-PAGE. Gels
were fixed, stained with CBB and dried before measuring
radioactivity in a Fuji-X Bio-Imager (FujiFilm Corp., Stockholm,
Sweden).
Luciferase Assays
HaCaT cells were transiently transfected with TGFb/Smad-
responsive promoter-reporter pCAGA12-MLP-luc for 36–48 h
prior to stimulation with TGFb. pCMV-b-gal or pEGFP were co-
transfected as controls for normalization. Additional constructs or
siRNAs were included in the transfections according to the figures.
Luciferase reporter assays were performed with the enhanced
luciferase assay kit from BD PharMingen, Inc. (BD Biosciences,
Stockholm, Sweden), according to the protocol of the manufac-
turer. Normalized promoter activity data are plotted in bar graphs
that represent average values from triplicate determinations with
standard deviations. Each independent experiment was repeated
at least twice.
Real-time RT PCR
HaCaT cells were treated as indicated in figures before
extraction of RNA using RNeasy (Qiagen AB, Solentuna,
Sweden). Measurements of mRNA expression were performed
as described [30]. The primers used for PCR amplification were:
human PARP-1, forward, 59-AAGCCCTAAAGGCTCAGAAC
G-39, reverse, 59-ACCATGCCATCAGCTACTCGGT-39; hu-
man PARP-2, forward, 59-GGTCATGGGCCAGCAAAAGGG-
39, reverse, 59-CATGAGCCTTCCCCACCTTGG-39; human
PARG, forward, 59-GAAAGGGACGACTGGCAGCGG-39, re-
verse, 59-CCAAAGGCACCACAGCCCCA-39; human GAPDH,
forward, 59-GGAGTCAACGGATTTGGTCGTA-39, reverse,
59-GGCAACAATATCCACTTTACC A-39; human Fibronectin,
forward, 59-CATCGAGCGGATCTGGCCCC-39, reverse, 59-
GCAGCTGACTCCGTTGCCCA-39; human SMAD7, forward,
59-ACCCGATGGATTTTCTCAAACC-39, reverse, 59-GCCA-




The differences between mRNA levels under control, gene
specific silencing and protein over-expression conditions were
evaluated statistically using a standard two-tailed t-test for samples
with unequal variance and two-sample with equal variance,
respectively. Significance is reported at p,0.05.
Supporting Information
Figure S1 GST-Smad proteins used for in vitro ADP-
ribosylation assays.
(EPS)
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Figure S2 Competition of Smad3 ADP-ribosylation by
cold b-NAD.
(EPS)
Figure S3 Endogenous PARG depletion suppressed
fibronectin and PAI-1 protein induction by TGFb1.
(EPS)
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